Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Life After Ozempic: How To Stay Metabolically Healthy After Ozempic

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by
Updated On
August 1, 2024

Ozempic, a GLP-1 receptor agonist generically known as semaglutide, has been used to manage type 2 diabetes mellitus and, more recently, in medical weight loss. Recent study findings show that Ozempic has a monthly growth rate of 83.9%. 

Ozempic has proved to be a significant advancement in diabetes treatment, offering effective glycemic control, increased insulin sensitivity, and suppression of glucagon secretion.

Ozempic's recent increase in popularity is mainly attributed to its beneficial effects on weight loss, which have attracted the medical community and beyond. Studies have shown potential weight regain after stopping semaglutide. One year after the withdrawal of once-weekly semaglutide injections and lifestyle interventions, patients gained two-thirds of their prior weight loss, with similar changes in cardiometabolic health. 

Maintaining metabolic health through lifestyle modification after discontinuing Ozempic is crucial to ensure long-lasting changes and optimal health. 

[signup]

What Is Ozempic?

Ozempic mimics GLP-1, a hormone naturally produced by the gut in response to food intake. It binds to GLP-1 receptors on pancreatic beta cells, reducing glucose levels in the body by stimulating increased insulin production.

GLP-1s also suppress glucagon, a hormone that raises blood sugar levels by releasing stored glucose from the liver. GLPs provide a feeling of fullness, leading to reduced food intake and weight loss. Study findings show a 12% reduction in body weight over 68 weeks. 

Common Uses

These mechanisms of GLP-1s are highly effective in managing type 2 diabetes mellitus and obesity and should be considered in treatment plans. Weight loss effects include appetite suppression, slower gastric emptying, and reduced caloric intake. 

Cardiovascular benefits have been found with the use of Ozempic as well, reducing stroke and heart attack risk. 

Why People Stop Using Ozempic 

While the key benefits of blood sugar control, appetite reduction, weight loss, and reduced cardiovascular risk are appealing, as with most pharmaceuticals, there are potential risks and side effects that providers and patients alike should consider. 

Side Effects

The most common side effects seen with Ozempic use are gastrointestinal effects, including: 

  • Nausea 
  • Bloating
  • Constipation
  • Diarrhea
  • Vomiting
  • Acid reflux

Further, the risk of hypoglycemia (low blood sugar levels) increases when the drug is combined with other blood sugar-lowering medications. It is vital to monitor glucose levels to ensure safety measures when utilizing diabetes medications. 

Pancreatitis (inflammation of the pancreas) is a medical emergency that has been reported in patients using Ozempic. Symptoms include nausea, vomiting, and abdominal pain that may radiate to the back. 

There have also been reports of kidney issues. Thus, patients with a history of kidney disease may not be ideal candidates for Ozempic, or a provider may opt to monitor kidney function closely. 

In animal studies, semaglutide has been associated with an increased risk of thyroid tumors. Although not confirmed in humans, providers should keep this in mind in patients with a history of thyroid cancer or other thyroid disorders. 

Other Considerations

Patients should plan to be taking semaglutide for a minimum of 3 to 6 months for medical weight loss, and people with type 2 diabetes likely will require a longer duration. 

Patients may stop semaglutide due to reaching their health goals, costs, or if they experienced unfavorable side effects. No matter the reason for discontinuation, it is essential for patients to work closely with providers in a management treatment plan to ensure long-lasting results. 

Staying Metabolically Healthy After Ozempic

It is possible to stay metabolically healthy after taking Ozempic. Here are some evidence-based tips:

Nutrition & Diet

A healthy diet is fundamental to maintaining stable blood sugars and weight. Balancing meals prevents blood sugar spikes and crashes, provides consistent energy levels, and reduces the risk of chronic health issues like cardiovascular disease

High-glycemic foods cause rapid increases in blood sugar levels. The glycemic index categorizes foods from 0 to 100 based on how significantly they impact blood sugar levels.

  • Low Glycemic Index (55 or less): Foods associated with a slower release of glucose into the bloodstream, including vegetables, most fruits, legumes, and whole grains.
  • Medium Glycemic Index (56-69): Foods that moderately impact blood sugar levels, like whole grain breads and brown rice.
  • High Glycemic Index (79 and above): Foods that spike blood sugar levels rapidly, such as sugary cereals, candy, fruit juices, soft drinks, white rice, white pasta, white bread, and pastries. 

A well-balanced diet includes low glycemic foods, portion monitoring, and incorporation of the following:

  • Protein: Lean proteins such as fish, poultry, beans, and tofu help increase satiety and stabilize blood sugar. The daily protein requirement varies depending on several factors, including age, sex, activity level, and overall health goals. The recommended daily allowance for protein is 0.8 grams per kilogram of body weight per day.
  • Healthy Fats: Unsaturated fats such as nuts, seeds, olive oil, and avocado are essential. On average, the recommended daily allowance of healthy fats for ages 19 and up includes 1.6 g per day for males and 1.1 g per day for females. 
  • High Fiber: High-fiber foods like vegetables, fruits, whole grains, and legumes slow the absorption of sugar. On average, the recommended daily allowance of fiber includes 25-30 grams. 
  • Complex Carbohydrates: Fruits, vegetables, whole grains, and legumes are digested slower than simple sugars and provide a steady release of glucose into the bloodstream. On average, the recommended daily diet includes 45-65% of complex carbohydrates.

Supplements

Providers may recommend certain supplements to support metabolic health, especially during or after a weight loss journey or health transformative process.

  • Berberine: Berberine has been referenced as "Nature's Ozempic" due to its beneficial impact on insulin sensitivity and blood sugar levels. some text
    • Recommended Dosing: 500 mg two-three times per day before meals
  • Chromium: Chromium improves glucose metabolism and enhances insulin effects.some text
    • Recommended Dosing: 25-35 mcg per day
  • Coenzyme Q10: CoQ10 supports mitochondrial function, the powerhouses of the cells, by enhancing energy production and reducing oxidative stress.some text
    • Recommended Dosing: 100-200 mg per day
  • Vitamin D: Vitamin D has many benefits, including supporting immune function, reducing inflammation, and enhancing insulin sensitivity. some text
    • Recommended Dosing: Based on blood levels, on average 1,000-2,000 IU per day
  • Omega-3 Fatty Acids: Fish oil or algae oil supplements support heart health, enhance insulin sensitivity, and reduce inflammation.some text
    • Recommended Dosing: 1-3 g per day of EPA/DHA
  • Magnesium: Magnesium helps regulate blood pressure, support glucose metabolism, and improve insulin sensitivity. some text
    • Recommended Dosing: 200-400 mg per day
  • Alpha-Lipoic Acid: ALA is an antioxidant that lowers inflammation and improves insulin sensitivity. some text
    • Recommended Dosing: 300-600 mg per day
  • Cinnamon Extract: Cinnamon helps lower blood sugar levels.some text
    • Recommended Dosing: 500-1,000 mg per day
  • Probiotics: Probiotics support gut health, influencing weight management and insulin sensitivity.some text
    • Recommended Dosing: On average, 1-10 billion CFUs per day
  • Fiber Supplements: Fiber helps control blood sugar levels and supports digestive health. some text
    • Recommended Dosing: 5-10 gm per day

Physical Activity 

Regular exercise and movement are irreplaceable in managing metabolic health and weight. Regular exercise boosts metabolism, increases muscle mass, supports cardiovascular health, and reduces inflammation. 

Exercise recommendations to consider: 

  • Aerobic Training: 150-300 minutes per week of moderate-intensity or 75-100 of vigorous intensity 
  • Resistance Training: Minimum 2 times per week, including 1-3 sets, or 8-12 reps, of 8-10 different exercises 

Lifestyle

Maintaining metabolic health for long-term success encompasses a whole-body approach, optimizing the mind, body, and spirit. Whole health involves managing stress, obtaining high-quality sleep, and having meaningful relationships with friends and family. 

Along with the incorporation of healthier habits, some habits negatively impact metabolic health, including:

  • Intake of high glycemic foods (highly processed foods, meats, and sugary foods)
  • Excessive alcohol intake
  • Nicotine and tobacco use
  • Environmental toxin exposure

Lab Testing for Metabolic Health

Lab testing is essential in diagnosing metabolic disorders and evaluating disease severity. 

Blood Sugar Monitoring 

Blood tests to monitor include:

These tests should continue to be monitored past Ozempic's discontinuation to trend the efficacy of treatment plans.

Lipid Profile

Due to the association between cardiovascular health and metabolic disease, a lipid panel should be assessed to evaluate the risk or level of cardiovascular disease. 

Additional Lab Tests

Ordering comprehensive lab testing is necessary for preventing, evaluating, and treating metabolic disorders. It presents providers with evidence of where the disorder is occurring. Providers interpret lab results and translate them into actionable steps for improving health based on patients' needs. 

Ongoing Medical Supervision

Regular check-ups are essential in tracking the progress of metabolic disease. These periodic visits are vital to continue past discontinuation of Ozempic to prevent weight gain, monitor blood sugar, reduce cardiovascular disease risk, and avoid potential complications of metabolic disease. 

A whole-body approach requires integrating different healthcare providers and specializations to maintain metabolic stability. This may include dieticians, physicians, endocrinologists, sleep specialists, acupuncturists, and physical therapists. 

Treatment plan adjustments may be necessary where additional medications or supplementations may be warranted. A flexible approach to managing health post-Ozempic is needed due to the complexity of metabolic health. 

[signup]

Key Takeaways

  • Critical strategies for managing metabolic health after Ozempic include focusing on a balanced and nutritious diet, regular exercise, stress management, and high-quality sleep. Nutrition and exercise are powerful protective and preventive agents against metabolic disease.
  • Regular monitoring through lab testing with a healthcare professional is critical for long-lasting results and provider review of treatment efficacy. Subsequent follow-ups support preventative methods for metabolic disease complications and cardiovascular disease prevention. 
  • Working with a healthcare provider empowers patients to take control of their health, encouraging them to stay on track with their health goals and leading to optimal health. 
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No items found.

A. Michael Lincoff, Kirstine Brown‐Frandsen, Colhoun, H. M., Deanfield, J., Emerson, S. S., Sille Esbjerg, Søren Hardt‐Lindberg, G. Kees Hovingh, Kahn, S. E., Kushner, R. F., Ildiko Lingvay, Tuğçe Kalaycı Oral, Marie Mide Michelsen, Plutzky, J., Tornøe, C. W., & Ryan, D. H. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England Journal of Medicine, 389(24). https://doi.org/10.1056/nejmoa2307563

Aggarwal, J. (2013). Probiotics and their Effects on Metabolic Diseases: An Update. JOURNAL of CLINICAL and DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2012/5004.2701

Ahmed, J., Riaz, M., & Imtiaz, R. (2021). Glycemic index and Glycemic load values. Pakistan Journal of Medical Sciences, 37(4). https://doi.org/10.12669/pjms.37.4.4555

Bertagna, B. (2024, January 9). The Prediabetes Diet: Building a Balanced Meal Plan for Optimal Blood Sugar Control. Rupa Health. https://www.rupahealth.com/post/the-prediabetes-diet-building-a-balanced-meal-plan-for-optimal-blood-sugar-control

Bikle, D. D. (2000). Vitamin D: Production, Metabolism and Mechanisms of Action (K. R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W. W. de Herder, K. Dhatariya, K. Dungan, J. M. Hershman, J. Hofland, S. Kalra, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, C. S. Kovacs, W. Kuohung, B. Laferrère, M. Levy, E. A. McGee, & R. McLachlan, Eds.). PubMed; MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK278935/#:~:text=The%20metabolism%20of%20vitamin%20D

Bryant, A. (2024, May 23). Thyroid Disorders: Types, Causes, and Treatments. Rupa Health. https://www.rupahealth.com/post/thyroid-disorders-types-causes-treatments

Bulsiewicz, W. J. (2023). The Importance of Dietary Fiber for Metabolic Health. American Journal of Lifestyle Medicine, 155982762311677-155982762311677. https://doi.org/10.1177/15598276231167778

C-Peptide. (n.d.). Rupa Health. Retrieved June 1, 2024, from https://www.rupahealth.com/biomarkers/c-peptide

Chromium. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/chromium

Cloyd, J. (2023a, June 19). A Functional Medicine Post Stroke Protocol: Testing, Therapeutic Diet, and Integrative Therapy Options. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-post-stroke-protocol-testing-supplements-and-integrative-therapy-options

Cloyd, J. (2023b, October 2). A Functional Medicine Approach to Stress Management. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-stress-management

Cloyd, J. (2023c, October 18). The 6 Most Important Uses of Omega-3s For Your Health. Rupa Health. https://www.rupahealth.com/post/the-6-most-important-uses-of-omega-3s-for-your-health

Cloyd, J. (2023d, December 1). A Functional Medicine Protocol For Balancing Blood Sugar. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-for-balancing-blood-sugar

Coenzyme Q10. (n.d.). Rupa Health. Retrieved June 11, 2024, from https://www.rupahealth.com/biomarkers/coq10

Daglis, S. (2024a, March 7). Emerging Biomarkers for Lipid Disorders: Beyond Traditional Lipid Profiles. Rupa Health. https://www.rupahealth.com/post/emerging-biomarkers-for-lipid-disorders-beyond-traditional-lipid-profiles

Daglis, S. (2024b, April 16). Berberine 101: What It Is, Benefits, and Side Effects. Rupa Health. https://www.rupahealth.com/post/berberine-101-what-it-is-benefits-and-side-effects

DePorto, T. (2023, January 17). What is Integrative Medicine? Rupa Health. https://www.rupahealth.com/post/what-is-integrative-medicine

Fasting Glucose. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/fasting-glucose

Fasting Insulin. (n.d.). Rupa Health. Retrieved June 1, 2024, from https://www.rupahealth.com/biomarkers/fasting-insulin

Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., Hurtado, M. D., & Acosta, A. (2022). Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open, 5(9), e2231982. https://doi.org/10.1001/jamanetworkopen.2022.31982

Hemoglobin A1C. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/hba1c

Hepatic Testing. (n.d.). Rupa Health. https://www.rupahealth.com/health-categories/hepatic

Holesh, J. E., Aslam, S., & Martin, A. (2021). Physiology, Carbohydrates. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459280/#:~:text=Healthy%20adult%20diets%20should%20include

Insulin. (n.d.). Rupa Health. Retrieved May 31, 2024, from https://www.rupahealth.com/biomarkers/insulin#:~:text=Insulin%20is%20a%20crucial%20hormone

Khakham, C. (2023a, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs

Khakham, C. (2023b, July 10). Understanding Environmental Toxins and Their Impact on Health. Rupa Health. https://www.rupahealth.com/post/understanding-environmental-toxins-and-their-impact-on-health

Krupa, K., Fritz, K., & Parmar, M. (2024). Omega-3 Fatty Acids. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK564314/#:~:text=Omega%2D3%20fatty%20acids%20are%20also%20believed%20to%20reduce%20high

Lee, S. (2024, February 9). What Are GLP-1 Drugs, And Why Are They Becoming Popular? Rupa Health. https://www.rupahealth.com/post/what-are-glp-1-drugs-and-why-are-they-becoming-popular

Lexchin, J., & Mintzes, B. (2023). Semaglutide: a new drug for the treatment of obesity. PubMed. https://doi.org/10.1136/dtb.2023.000007

Magda Sara Wojtara, Mazumder, A., Syeda, Y., & Nikodem Mozgała. (2023). Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management. Advances in Medicine, 2023, 1–7. https://doi.org/10.1155/2023/9946924

Mantle, D., Lopez-Lluch, G., & Hargreaves, I. P. (2023). Coenzyme Q10 Metabolism: A Review of Unresolved Issues. International Journal of Molecular Sciences, 24(3), 2585. https://doi.org/10.3390/ijms24032585

McKeown, N. M., Fahey, G. C., Slavin, J., & van der Kamp, J.-W. (2022). Fibre Intake for Optimal health: How Can Healthcare Professionals Support People to Reach Dietary recommendations? BMJ, 378, e054370. https://doi.org/10.1136/bmj-2020-054370

Mollazadeh, H., & Hosseinzadeh, H. (2016). Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iranian Journal of Basic Medical Sciences, 19(12), 1258–1270. https://doi.org/10.22038/ijbms.2016.7906

National Institutes of Health. (2022, June 2). Office of dietary supplements - dietary supplement fact sheet: Chromium. Nih.gov. 

National Institutes of Health. (2023, February 15). Office of Dietary Supplements - Omega-3 Fatty Acids. Nih.gov. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/

https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/

Nguyen, H., & Gupta, V. (2021). Alpha-Lipoic Acid. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK564301/

Och, A., Och, M., Nowak, R., Podgórska, D., & Podgórski, R. (2022). Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules (Basel, Switzerland), 27(4), 1351. https://doi.org/10.3390/molecules27041351

Ozempic® Side Effects | Ozempic® (semaglutide) injection 0.5 mg or 1 mg. (2023, August). Www.ozempic.com. https://www.ozempic.com/how-to-take/side-effects.html

Patel, F., Gan, A., Chang, K., & Vega, K. J. (2023). Acute Pancreatitis in a Patient Taking Semaglutide. Cureus, 15(8), e43773. https://doi.org/10.7759/cureus.43773

Perera, H. (2024, April 11). The Ultimate Fiber Foods List: Boost Your Health with High-Fiber Choices. Rupa Health. https://www.rupahealth.com/post/ultimate-fiber-foods-list

Preston, J. (2022, November 10). What's The Difference Between Good And Bad Dietary Fat? Rupa Health. https://www.rupahealth.com/post/dietary-fat-the-good-the-bad-and-the-misunderstood

Renal Testing. (n.d.). Rupa Health. https://www.rupahealth.com/health-categories/renal

Seo, J. W., & Park, T. J. (2008). Magnesium Metabolism. Electrolytes & Blood Pressure : E & BP, 6(2), 86–95. https://doi.org/10.5049/EBP.2008.6.2.86

Shu, Y., He, X., Wu, P., Liu, Y., Ding, Y., & Zhang, Q. (2022). Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.996179

Smits, M. M., & Van Raalte, D. H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.645563

Stanford, J. (2024, March 19). Exploring the Link Between Insulin Resistance and Obesity. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-obesity

Sweetnich, J. (2023a, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Sweetnich, J. (2023b, May 4). Getting to Know Vitamin D: From Testing to Supplementing and Meeting your RDA's. Rupa Health. https://www.rupahealth.com/post/vitamin-d-101-testing-rdas-and-supplementing

Thyfault, J. P., & Bergouignan, A. (2020). Exercise and metabolic health: beyond skeletal muscle. Diabetologia, 63(8), 1464–1474. https://doi.org/10.1007/s00125-020-05177-6

Tomasz Chomiuk, Niezgoda, N., Artur Mamcarz, & Śliż, D. (2024). Physical activity in metabolic syndrome. Frontiers in Physiology, 15. https://doi.org/10.3389/fphys.2024.1365761

Watanabe, J. H., Kwon, J., Nan, B., & Reikes, A. (2023). Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2023.10.002

Weinberg, J. (2022, October 4). Pancreatitis: Causes, Risk Factors, and Treatments. Www.rupahealth.com. https://www.rupahealth.com/post/pancreatitis-causes-risk-factors-and-treatments

Weinberg, J. (2023, December 19). The Science of Sleep: Functional Medicine for Restorative Sleep. Rupa Health. https://www.rupahealth.com/post/the-science-of-sleep-functional-medicine-for-restorative-sleep

Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725

Wu, G. (2016). Dietary Protein Intake and Human Health. Food & Function, 7(3), 1251–1265. https://doi.org/10.1039/c5fo01530h

Yoshimura, H. (2024, March 21). What is the Difference Between Glycemic Index and Glycemic Load? Rupa Health. https://www.rupahealth.com/post/glycemic-index-glycemic-load-difference

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source